These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13323966)

  • 1. [Value of erythrosedimentation rate in chronic peripheral obliterating arterial diseases].
    CONTI A
    Riforma Med; 1956 Mar; 70(13):360-3. PubMed ID: 13323966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of glutamic-oxalacetic and pyruvic transaminase activity in the serum of patients with chronic obliterating arterial diseases].
    AZZINI CA; GHISELLINI F
    Chir Organi Mov; 1961 Nov; 50():368-72. PubMed ID: 13863594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remote results of lumbar gangliectomy in chronic peripheral obliterating arterial diseases].
    FABI M; MALAGU I; VITA F; FABBRI LF; RANERI D
    Arcisp S Anna Ferrara; 1962; 15():363-95. PubMed ID: 13891188
    [No Abstract]   [Full Text] [Related]  

  • 4. [5-hydroxytryptamine in peripheral arteriopathies].
    DELLO RUSSO R; PALADINO L; FATI S
    Riforma Med; 1960 Jun; 74():691-4. PubMed ID: 13815698
    [No Abstract]   [Full Text] [Related]  

  • 5. [Syncardial massage in the treatment of peripheral chronic obliterating arteriopathies].
    TESSAROLO N; MARIOT A
    Acta Chir Ital; 1959; 15():717-35. PubMed ID: 13837579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of regidine in normal persons and in patients with chronic obliterating peripheral arteriopathies].
    EPPINGER S
    Minerva Med; 1956 Jun; 47(49):1940-3. PubMed ID: 13348333
    [No Abstract]   [Full Text] [Related]  

  • 7. The diagnosis and surgical treatment of peripheral obliterating arterial diseases; with special reference to a new technique of aortography.
    DE REUS HD; VINK M
    Arch Chir Neerl; 1955; 7(2):105-23. PubMed ID: 13239451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution to the study of thrombophilia in chronic obliterating arteriopathy of the extremities].
    VERGANI G; SIDERI GC
    Osp Maggiore; 1961 May; 49():209-18. PubMed ID: 13780845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function in patients with chronic obliterating peripheral arteriopathy].
    CURZIO G; JOVINO R; CONDURSO R
    Riforma Med; 1959 Oct; 73():1157-9. PubMed ID: 13813420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relation between mesenchymal mucopolysac-charides and blood mucopolysaccharides in peripheral obliterating arteriopathy].
    RADINO G
    Arch Sci Med (Torino); 1960 Feb; 109():180-202. PubMed ID: 14435715
    [No Abstract]   [Full Text] [Related]  

  • 11. [Creatine metabolism in peripheral obstructive arteriopathy. (Pre- and post- operative study of the regional and systemic venous blood)].
    JOVINO R; MUSELLA S; GRASSI M
    Riforma Med; 1961 May; 75():596-601. PubMed ID: 13790866
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemoxometric findings in spontaneous obliterating vascular diseases of the extremities].
    SCALABRINO R; PASQUARIELLO G
    Minerva Med; 1953 May; 44(36):1181-5. PubMed ID: 13072017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tissue histamine levels in some cases of peripheral obliterating arteriosclerosis].
    MANZI G; CILENTO A
    Minerva Chir; 1959 Aug; 14():949-52. PubMed ID: 14420796
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON PERIOSTEAL CHANGES IN PERIPHERAL OBLITERATING ARTERIAL CIRCULATORY DISORDERS].
    SCHNEIDER VM; SCHNEPPER E; HILLENBRAND HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1963 Aug; 99():228-34. PubMed ID: 14047700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of the arteriolo-capillary circulation in subjects of chronic peripheral obliterating arteriopathy after treatment with 1, 1-(beta-hydroxypropyl)-theobromine].
    GUAGLIANO G; STOPPANI L; VITTORI F
    Minerva Med; 1959 Nov; 50():3815-9. PubMed ID: 13829927
    [No Abstract]   [Full Text] [Related]  

  • 16. [THROMBOCYTE SEDIMENTATION AND LEUKOCYTE SEDIMENTATION IN PERIPHERAL OBSTRUCTIVE ARTERIOPATHY OF AN ARTERIOSCLEROTIC NATURE].
    CORSALE C; SPAMPINATO N
    Rass Int Clin Ter; 1964 Feb; 44():126-35. PubMed ID: 14137138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amputation in chronic obliterating peripheral arteriopathies].
    DE TOLEDO OM; LEAO LE; BUENO NETO J
    Rev Paul Med; 1953 Oct; 43(4):330-40. PubMed ID: 13134971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observations on the behavior of some tests of blood coagulation in the study of obliterating arteriopathies of the extremities].
    VERGANI G; SIDERI GC
    Osp Maggiore; 1961 Jun; 49():237-42. PubMed ID: 13780846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlation between the structural and chemical changes of the mesenchyma and the humoral picture in peripheral obliterating arteriopathy].
    AGRESTI A; D'ALESSIO E
    Rass Int Clin Ter; 1959 Oct; 39():933-40. PubMed ID: 13792064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Doctrinal bases and practical value of adenosinetriphosphate in therapy of intermittent claudication and of other phenomena of obliterating peripheral arteriopathies].
    BIANCHI V; GALLO G
    Minerva Med; 1953 Apr; 44(33):1053-67. PubMed ID: 13071987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.